“Bioprinting’s importance for pharmaceutical analysis is paramount now, not only for potential Covid-19 treatments but also for testing treatments for cancer and other diseases,” states a recent article from [...]
Brinter is assisting the University of Gothenburg in the RESTORE project with the optimization of the nanocellulose/alginate-based bioink to improve its printability and cartilage tissue regeneration. For test purposes, [...]
Horizon 2020 Novum project news: In a major step forward in the field of additive manufacturing, BRINTER has demonstrated that it can successfully print constructs from cellulose granulates, a [...]
Brinter customers and partners frequently ask us about the history of the modular 3D bioprinter - Brinter. Here you can see the important milestones in a one-pager. [...]
In May 2020, Brinter Ltd. was selected as one of the top eight 3D bioprinting startups in the world by StartUs Insights. The Austrian data science and research company [...]
